A Bayesian Approach to the Design of Phase II Clinical Trials

Recommendations

Approximately optimal designs for phase II clinical studies
Sample Size Determination for Phase II Clinical Trials Based on Bayesian Decision Theory
A Bayesian decision approach for sample size determination in phase II trials
Bayesian Optimal Design for Phase II Screening Trials
Decision-Theoretic Designs for Phase II Clinical Trials Allowing for Competing Studies

Cited in

(45)

Approximately optimal designs for phase II clinical studies
Bayes rules for a clinical-trials model with dichotomous responses
Bayesian designs for phase I--II clinical trials
A behavioural Bayes approach to the determination of sample size for clinical trials considering efficacy and safety: imbalanced sample size in treatment groups
Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials
Bayesian randomized clinical trials: A decision-theoretic sequential design
Use of bayesian analysis to design of clinical trials with one treatment
MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION
Bayesian approach to determine the number of subsequent users of a new treatment
Is the FDA too conservative or too aggressive?: a Bayesian decision analysis of clinical trial design
Design and Analysis of Phase II Cancer Trials: A Review of Statistical Methods and Guidelines for Medical Researchers
Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes
Determination of the optimal sample size for a clinical trial accounting for the population size
Monitoring futility and efficacy in phase II trials with Bayesian posterior distributions—A calibration approach
Bayesian design for clinical trials with a constraint on the total available dose
Bayesian Design and Analysis of Active Control Clinical Trials
Bayesian enhancement two-stage design for single-arm phase II clinical trials with binary and time-to-event endpoints
Motivating sample sizes in adaptive phase I trials via Bayesian posterior credible intervals
Phase I (or Phase II) Dose-Ranging Clinical Trials: Proposal of a Two-Stage Bayesian Design
Bayesian designs with frequentist and Bayesian error rate considerations
Implementation of a Bayesian Design in a Dose‐Escalation Study of an Experimental Agent in Healthy Volunteers
A Bayesian seamless phase I–II trial design with two stages for cancer clinical trials with drug combinations
Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndrome
Sample sizes of clinical trials: for science and decision making
Bayesian design of biosimilars clinical programs involving multiple therapeutic indications
Bayesian doubly adaptive randomization in clinical trials
Bayesian design of clinical trials using joint cure rate models for longitudinal and time-to-event data
A Bayesian adaptive phase I/II clinical trial design with late‐onset competing risk outcomes
scientific article; zbMATH DE number 1990010 (Why is no real title available?)
Optimal Bayesian two-phase designs
A Bayesian decision approach for sample size determination in phase II trials
Adaptive data collection for intraindividual studies affected by adherence
Randomized phase III oncology trials: a survey and empirical Bayes inference
An optimal Bayesian predictive probability design for phase II clinical trials with simple and complicated endpoints
Bayesian meta-experimental design: evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes
scientific article; zbMATH DE number 5224906 (Why is no real title available?)
Bayesian statistics and the efficiency and ethics of clinical trials
Bayesian Approaches to Randomized Trials
Approaches for Optimal Sequential Decision Analysis in Clinical Trials
Decision-theoretic designs for a series of trials with correlated treatment effects using the Sarmanov multivariate beta-binomial distribution
Bayesian Optimal Design for Phase II Screening Trials
On an approach to Bayesian sample sizing in clinical trials
Practical Bayesian Guidelines for Phase IIB Clinical Trials
scientific article; zbMATH DE number 4155731 (Why is no real title available?)
Bayesian enrichment strategies for randomized discontinuation trials

This page was built for publication: A Bayesian Approach to the Design of Phase II Clinical Trials

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3201545)